Activity of the multi-targeted kinase inhibitor, AT9283, in imatinib-resistant BCR-ABL positive leukemic cells.

Activity of the multi-targeted kinase inhibitor, AT9283, in imatinib-resistant BCR-ABL positive leukemic cells.

Kyoto University (京都大学) === 0048 === 新制・課程博士 === 博士(医科学) === 甲第15993号 === 医科博第19号 === 新制||医科||2(附属図書館) === 28572 === 京都大学大学院医学研究科医科学専攻 === (主査)教授 髙折 晃史, 教授 武田 俊一, 教授 松岡 雅雄 === 学位規則第4条第1項該当...

Full description

Bibliographic Details
Main Author: Tanaka, Ruriko
Other Authors: 髙折, 晃史
Format: Others
Language:English
Published: Kyoto University 2011
Subjects:
491
Online Access:http://hdl.handle.net/2433/142109
id ndltd-kyoto-u.ac.jp-oai-repository.kulib.kyoto-u.ac.jp-2433-142109
record_format oai_dc
spelling ndltd-kyoto-u.ac.jp-oai-repository.kulib.kyoto-u.ac.jp-2433-1421092017-09-09T03:47:46Z Activity of the multi-targeted kinase inhibitor, AT9283, in imatinib-resistant BCR-ABL positive leukemic cells. イマチニブ抵抗性BCR-ABL陽性白血病細胞におけるマルチターゲット型キナーゼ阻害剤AT9283の作用機序と有用性に関する検討 Tanaka, Ruriko 髙折, 晃史 武田, 俊一 松岡, 雅雄 田中, 瑠璃子 タナカ, ルリコ 491 Kyoto University (京都大学) 0048 新制・課程博士 博士(医科学) 甲第15993号 医科博第19号 新制||医科||2(附属図書館) 28572 京都大学大学院医学研究科医科学専攻 (主査)教授 髙折 晃史, 教授 武田 俊一, 教授 松岡 雅雄 学位規則第4条第1項該当 2011-07-07T02:57:27Z 2011-07-07T02:57:27Z 2011-03-23 2011-03-23 DAM Thesis or Dissertation http://hdl.handle.net/2433/142109 eng application/pdf Kyoto University 京都大学
collection NDLTD
language English
format Others
sources NDLTD
topic 491
spellingShingle 491
Tanaka, Ruriko
Activity of the multi-targeted kinase inhibitor, AT9283, in imatinib-resistant BCR-ABL positive leukemic cells.
description Kyoto University (京都大学) === 0048 === 新制・課程博士 === 博士(医科学) === 甲第15993号 === 医科博第19号 === 新制||医科||2(附属図書館) === 28572 === 京都大学大学院医学研究科医科学専攻 === (主査)教授 髙折 晃史, 教授 武田 俊一, 教授 松岡 雅雄 === 学位規則第4条第1項該当
author2 髙折, 晃史
author_facet 髙折, 晃史
Tanaka, Ruriko
author Tanaka, Ruriko
author_sort Tanaka, Ruriko
title Activity of the multi-targeted kinase inhibitor, AT9283, in imatinib-resistant BCR-ABL positive leukemic cells.
title_short Activity of the multi-targeted kinase inhibitor, AT9283, in imatinib-resistant BCR-ABL positive leukemic cells.
title_full Activity of the multi-targeted kinase inhibitor, AT9283, in imatinib-resistant BCR-ABL positive leukemic cells.
title_fullStr Activity of the multi-targeted kinase inhibitor, AT9283, in imatinib-resistant BCR-ABL positive leukemic cells.
title_full_unstemmed Activity of the multi-targeted kinase inhibitor, AT9283, in imatinib-resistant BCR-ABL positive leukemic cells.
title_sort activity of the multi-targeted kinase inhibitor, at9283, in imatinib-resistant bcr-abl positive leukemic cells.
publisher Kyoto University
publishDate 2011
url http://hdl.handle.net/2433/142109
work_keys_str_mv AT tanakaruriko activityofthemultitargetedkinaseinhibitorat9283inimatinibresistantbcrablpositiveleukemiccells
AT tanakaruriko imachinibudǐkàngxìngbcrablyángxìngbáixuèbìngxìbāoniokerumaruchitāgettoxíngkināzezǔhàijìat9283nozuòyòngjīxùtoyǒuyòngxìngniguānsurujiǎntǎo
_version_ 1718529127227588608

Similar Items